[HTML][HTML] Canadian Cardiovascular Society clinical practice update on contemporary management of the patient with hypertrophic cardiomyopathy
AM Crean, A Adler, L Arbour, J Chan… - Canadian Journal of …, 2024 - Elsevier
Numerous guidelines on the diagnosis and management of hypertrophic cardiomyopathy
(HCM) have been published, by learned societies, over the past decade. Although helpful …
(HCM) have been published, by learned societies, over the past decade. Although helpful …
Atrial fibrillation in hypertrophic cardiomyopathy
A Weissler-Snir, S Saberi, TC Wong, A Pantazis… - JACC: Advances, 2024 - jacc.org
Atrial fibrillation (AF) is common among patients with hypertrophic cardiomyopathy (HCM)
with a prevalence> 25%. AF in HCM is associated with a high risk of stroke and can be a …
with a prevalence> 25%. AF in HCM is associated with a high risk of stroke and can be a …
[HTML][HTML] From atrial fibrillation management to atrial myopathy assessment: the evolving concept of left atrium disease in hypertrophic cardiomyopathy
C Fumagalli, C Zocchi, M Ciabatti, A Milazzo… - Canadian Journal of …, 2024 - Elsevier
Hypertrophic cardiomyopathy (HCM) is the most prevalent genetically inherited
cardiovascular disorder in adults and a significant cause of heart failure and sudden cardiac …
cardiovascular disorder in adults and a significant cause of heart failure and sudden cardiac …
Clinical and pathophysiologic determinants of catheter ablation outcome in hypertrophic cardiomyopathy with atrial fibrillation
Background Hypertrophic cardiomyopathy (HCM) is frequently associated with atrial
fibrillation (AF). We compared clinical, echocardiographic, and electrophysiological …
fibrillation (AF). We compared clinical, echocardiographic, and electrophysiological …
Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Systematic Review and Meta-analysis of Anticoagulation Strategy
F Oliveri, A Pepe, A Bongiorno, A Fasolino… - American Journal of …, 2023 - Springer
Background Atrial fibrillation (AF) frequently complicates hypertrophic cardiomyopathy
(HCM), and anticoagulation significantly decreases the risk of stroke in this population. To …
(HCM), and anticoagulation significantly decreases the risk of stroke in this population. To …
[HTML][HTML] Efficacy of Vein of Marshall Ethanol Infusion Added to Left Atrial Anatomical Ablation for Treatment of Persistent Atrial Fibrillation in Patients with Hypertrophic …
T Luo, T Liu, B Cui, X Li, J Zhang, G Wu - Reviews in Cardiovascular …, 2023 - imrpress.com
Background: Radiofrequency catheter ablation (RFCA) has been shown to have low efficacy
for the treatment of persistent atrial fibrillation (AF) in patients with hypertrophic …
for the treatment of persistent atrial fibrillation (AF) in patients with hypertrophic …
Left ventricle late gadolinium enhancement and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy: Another brick towards a precise approach.
S Albani, M Merlo - International Journal of …, 2024 - internationaljournalofcardiology.com
Atrial fibrillation (AF) is a common finding in patients affected by hypertrophic
cardiomyopathy (HCM), with a prevalence between 20–30% and an annual incidence of 2 …
cardiomyopathy (HCM), with a prevalence between 20–30% and an annual incidence of 2 …
[PDF][PDF] Crean, AM, Adler, A, Arbour, L, Chan, J, Christian, S, Cooper, RM, Garceau, P, Giraldeau, G, Heydari, B, Laksman, Z, Mital, S, Ong, K, Overgaard, C, Ruel, M …
AM Crean - researchonline.ljmu.ac.uk
Canadian Cardiovascular Society Clinical Practice Update on Contemporary Management of
the Patient With Hypertrophic Cardiomyopa Page 1 Crean, AM, Adler, A, Arbour, L, Chan, J …
the Patient With Hypertrophic Cardiomyopa Page 1 Crean, AM, Adler, A, Arbour, L, Chan, J …